'She had the courage to not cow down before the entire law and order apparatus, to remain sane and human despite inhuman suffering meted out to her and her family.'
Of the 18 local transmission patients, 16 had come in direct contact with foreign-returned infected persons while two had visited places like Delhi and Jaipur, said Jayanti Ravi, Principal Secretary, Health.
'One coronavirus positive patient, female, 85 years, died in Ahmedabad today. She had traveled abroad, and after developing symptoms of COVID-19, she was admitted at civil hospital on March 22,' the health department said in a tweet.
As of Friday, Gujarat's COVID-19 count stood at 7,403 cases, of which 5,260 were from Ahmedabad district alone, while of the 449 deaths in the state, 343 were from the city.
The Congress has alleged that the Gujarat government was playing with the lives of coronavirus patients to promote 'Dhaman-1' ventilators made by a firm `owned by Chief Minister Vijay Rupani's friend'. The ruling Bharatiya Janata Party called the allegations levelled by the Congress on Thursday as baseless and said the opposition party was maligning the image of a local manufacturer.
The second highest number of coronavirus cases in the country. The worst mortality rate among states. A none too impressive recovery rate. Surely this doesn't speak highly of the famed Gujarat model, so what went wrong?
Prime Minister Narendra Modi condoled the tragic loss of lives in the fire.
Over 29 lakh tourists visited the Statue of Unity, located near the Sardar Sarovar Dam, since it was inaugurated and this generated a revenue of Rs 82.51 crore, the government had told the assembly in December last year
20 babies have died in the past three days at the facility.
While Prime Minister Narendra Modi's Ayushman Bharat health care scheme is just a slogan for the moment, it is the state's Mukhyamantri Amrutum health assurance scheme which is a comforting reality for many.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances